Read our Advances in our Work
CAR-T therapy is often very costly and not effective in killing solid tumours.
Prof Nicholas Gascoigne, Dr Wu Ling and team have discovered the by manipulating the signalling molecules in the CAR-T cells, the efficacy of these cells can be improved so that they have a better ability to persist in the host and to kill the tumour. This also improves the CAR-T function in a solid tumour model.
Cancer is still the leading cause of death in Singapore according to the Ministry of Health Statistics. One of the
Check out Dr Frank Sen Hee TAY’s latest paper on using machine learning and magnetic resonance brain imaging to study the
CAR-T therapy is often very costly and not effective in killing solid tumours. Prof Nicholas Gascoigne, Dr Wu Ling and team
Multiple Sclerosis (MS) is a debilitating disease with few therapeutic options. Sphingosine-1-phosphate (S1P) is a potent lipid mediator secreted by
Did you know that around 1 in 25 people in Singapore have chronic hepatitis B infection? Infection of Hepatitis B
Most of us have probably taken a nonsteroidal anti-inflammatory drug (NSAID) such as ibuprofen, mefenamic acid or naproxen for some
© National University of Singapore. All Rights Reserved.